Founder, Chief Science Officer and Chairman, Longeveron Longeveron has licensed issued US Patent 12,168,028 B2, entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of M ...

A critical review of cell-based and cell product-based therapies for the treatment of heart failure details 20 years of completed and ongoing clinical trials. While none has yet gained medical ...

“The history of the development of life-saving medical therapies for heart failure serves as an important lesson that we should remain hopeful of the promise of cell therapy in heart failure,” Jianyi ...

Full original reading on Techno-Science. A new biological patch, designed from heart cells grown in the laboratory, could bring a glimmer of hope in the treatment of advanced heart failure.

Childhood heart disease is the leading cause of infant mortality and heart problems are the most common birth defects for infants, but new research indicates stem cells could be key in treating ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell therapy ...

May 11, 2011 - Stem cell therapy in sports medicine is spotlighted after New York Yankees pitcher Bartolo Colon is revealed to have had fat and bone marrow stem cells injected into his injured ...

New medical discoveries show that stem cell treatment may help patients cope with both bone problems and brain diseases. Recent studies have also shown that stem cell therapy could reduce heart ...

May 11, 2011 – Stem cell therapy in sports medicine is spotlighted after New York Yankees pitcher Bartolo Colon is revealed to have had fat and bone marrow stem cells injected into his injured ...